Marshall Wace
AMRX icon

Marshall Wace’s Amneal Pharmaceuticals AMRX Stock Holding History

Marshall Wace’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-472,137
Closed -$2.52M – 3832
2021
Q3 		$2.52M Sell
472,137
-383,916
-45% -$1.93M 0.01% 1386
2021
Q2 		$4.38M Sell
856,053
-676,844
-44% -$3.85M 0.02% 924
2021
Q1 		$10.3M Buy
1,532,897
+1,498,033
+4,297% +$8.3M 0.05% 435
2020
Q4 		$160K Buy
+34,864
New +$154K ﹤0.01% 1768
2020
Q1 		– Sell
-609,935
Closed -$2.94M – 1607
2019
Q4 		$2.94M Buy
609,935
+599,456
+5,721% +$2.08M 0.02% 699
2019
Q3 		$30K Buy
+10,479
New +$36.6K ﹤0.01% 1564
2019
Q2 		– Sell
-492,275
Closed -$6.98M – 1318
2019
Q1 		$6.98M Buy
492,275
+408,533
+488% +$5.4M 0.07% 361
2018
Q4 		$1.13M Buy
+83,742
New +$1.51M 0.01% 879

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Marshall Wace's AMRX Position: Q4 2021 in Review

Marshall Wace sold out of Amneal Pharmaceuticals (AMRX) in Q4 2021, closing a stake of 472,137 shares — an estimated $2.52M sold.

Marshall Wace first reported a position in AMRX in Q4 2018 and held it in 8 quarters. The position peaked at $10.3M in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q4 2021.

  • Marshall Wace reported no remaining Amneal Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Marshall Wace sold 472,137 Amneal Pharmaceuticals shares in Q4 2021, an estimated $2.52M.
  • Marshall Wace first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 8 quarters.
  • Marshall Wace's Amneal Pharmaceuticals position peaked at $10.3M in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.